GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The UnitBenzinga • 01/15/22
Vir, GSK ask FDA to update EUA for their monoclonal antibody to include intramuscular administrationMarket Watch • 01/13/22
GlaxoSmithKline (GSK) Gains But Lags Market: What You Should KnowZacks Investment Research • 01/12/22
GlaxoSmithKline plc's (GSK) CEO Emma Walmsley Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)Seeking Alpha • 01/11/22
GlaxoSmithKline, Vir shares up as U.S. orders more doses of COVID treatment sotrovimabMarket Watch • 01/11/22
GlaxoSmithKline to ship 600,000 more doses of COVID treatment sotrovimab to U.S.Market Watch • 01/11/22
GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 dosesMarket Watch • 01/06/22
Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of DirectorsPRNewsWire • 12/27/21
Stock Market Today: Stock Futures Rise After Omicron-Led Sell-Off; Nike and Micron Soar On Strong Earnings; Pfizer and GSK Make FDA Breakthrough With HIV DrugStockmarketcom • 12/21/21
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative OptionBenzinga • 12/21/21